Intertek Pharmaceutical Services
Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees
Intertek Pharmaceutical Services Service Provider of gmp & cmc services, bioanalytical services & biopharmaceutical services
Recent Acquisitions Intertek's active acquisition strategy, including the recent purchase of Qtest, Aepvi, and Suplilab, demonstrates their focus on expanding testing and certification services across various markets. This creates opportunities for suppliers of testing equipment, laboratory supplies, and specialized testing technologies to partner or provide solutions aligned with their growth.
Geographic Expansion Expansion into Colombia and other regions through acquisitions indicates Intertek's drive to strengthen its global footprint in pharmaceutical and safety testing markets. Businesses offering localized or region-specific compliance and testing solutions can find relevant sales opportunities within these expanding markets.
Industry Focus Intertek's involvement in bioanalytical, GMP, CMC, and biopharmaceutical services highlights a demand for advanced analytical instrumentation, process validation tools, and quality assurance technologies. Suppliers of cutting-edge laboratory equipment and software solutions could leverage this to offer tailored products for biotech and pharma testing needs.
Intertek Pharmaceutical Services uses 8 technology products and services including SCIEX, Adobe, Canva, and more. Explore Intertek Pharmaceutical Services's tech stack below.
| Intertek Pharmaceutical Services Email Formats | Percentage |
| First.Last@intertek.com | 97% |
| Last.First@intertek.com | 1% |
| First.Middle@intertek.com | 1% |
| FirstLast@intertek.com | 1% |
Pharmaceutical ManufacturingEngland, United Kingdom51-200 Employees
Intertek Pharmaceutical Services Service Provider of gmp & cmc services, bioanalytical services & biopharmaceutical services
Intertek Pharmaceutical Services's revenue is estimated to be in the range of $10M$25M
Intertek Pharmaceutical Services's revenue is estimated to be in the range of $10M$25M